January 15, 2025
JP Morgan Healthcare Conference – day 3
Breaking: The consumer price index increased 0.4% on the month, putting the 12-month inflation rate at 2.9%. Economists had been looking for respective readings of 0.3% and 2.9%. However, excluding food and energy, the core CPI annual rate was 3.2%, a notch down from the month before and slightly better than the 3.3% forecast. The core measure rose 0.2% on a monthly basis, also 0.1 percentage point less than expected.
Pre-open Indications: Still, many on the slippery slope, with a few ascensions
Never leave an investor uninform
January 11, 2025
SAGE confirmed (2/10/25) that Biogen (BIIB) has submitted an unsolicited, nonbinding proposal to acquire all of the outstanding shares of SAGE not already owned by BIIB for $7.22 per share.
SAGE closed down -$0.30 or -5.13% at $5.55 with an aftermarket value of +2.56 or +46.11% to $8.11
January 17, 2025
Yet the cell and gene therapy sector stumbled as the JP Morgan Healthcare Conference didn’t light-up the stories
Investors are looking ahead to next week, as Donald Trump is set to be inaugurated as president for the 2nd time.
I say today what others won't, so you can do what others can't!
Never leave an investor uninformed!
The week in review
January 11, 2025
SAGE confirmed (2/10/25) that Biogen (BIIB) has submitted an unsolicited, nonbinding proposal to acquire all of the outstanding shares of SAGE not already owned by BIIB for $7.22 per share. SAGE closed down -$0.30 or -5.13% at $5.55 with an aftermarket value of +2.56 or +46.11% to $8.11
January 1, 2025
“Last year's words .... belong to last year's language. And next year's words ... await another voice” — TS Eliot
December 23, 2024
To RegMed Investor (RMi) readers, one and all … It’s been quite the year, 2024; more bottoms than peaks, a blend of fortune and losses. To you ... Christmas and Holiday wishes go a long way in maintaining relationships that have created bonds that WILL only become stronger with time. Whether you've been reading my insights from writings; I have been pretty damn right through the year! 2025 is just another road to be traveled … in safety! So, as you navigate the holiday hustle, remember to take a moment for some well-deserved relaxation and maybe a cocktail or two. Wishing you all a holiday season and fewer reasons to check your email!
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
